Researchers examined cancer rates of organ transplant recipients, finding elevated colorectal cancer and non-Hodgkin lymphoma rates, according to a study presented at ACG 2018, Oct. 5-10 in Philadelphia.
GI & Endoscopy
Colorectal cancer mortality rates are expected to rise as the world's population ages, according to research in the International Journal of Cancer.
Edward Lebovics, MD, is Valhalla, N.Y.-based Westchester Medical Center's gastroenterology and hepatobiliary diseases section chief and director.
Here are four updates from gastroenterology companies from the past week:
Charles Adelmann, MD, of Norwalk, Conn.--based Soundview Medical Associates spoke with Becker's ASC Review about the biggest issues in gastroenterology today.
Advertisement
Landos Biopharma reported results from its phase 1 trial of BT-11, an ulcerative colitis and Crohn's disease treatment.
EnteraSense secured $4 million (€3.5 million) in funding for its gastrointestinal tract bleed-detecting capsule, Med-Tech Innovation News reports.
Exact Sciences expects to post fourth quarter 2018 revenues between $142.5 million to $143.5 million, a 64 percent year-over-year increase.
Gastroenterology will have the greatest growth in the ASC marketplace over the next eight years, according to a Future Market Insights report.
Miguel Regueiro, MD, is the Cleveland Clinic's gastroenterology, hepatology and nutrition department chair.